Management tracks

Prescription and OTC pharma Taro Pharmaceutical Industries Ltd. (NYSE:TARO) said Uday Baldota will replace Kal Sundaram as its CEO, effective April 2017. Baldota is EVP and CFO at Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA). Abhay Gandhi, who is CEO of Sun's North America operations, will be Taro's interim CEO from Jan. 1 until Baldota's arrival.

Cell therapy company bluebird bio Inc. (NASDAQ:BLUE) named Susanna High COO and Andrew Obenshain SVP and head of Europe. High was SVP of strategy and business integration at Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY). Obenshain was general manager of France and Benelux at Shire plc (LSE:SHP; NASDAQ:SHPG)...